Cardiovascular outcome trials (CVOTs) with GLP-1RAs evaluated seven agents, with liraglutide, semaglutide, and dulaglutide showing significant CV and renal benefits
24 Lifestyle interventions, such as improved diet and increased physical activity, are the cornerstone of obesity management
It is important to maintain your diabetes medication regimen during illness
If you are taking compounded versions of these drugs, please heed the FDA's advice
Regulatory & manufacturing hurdles Finally, translating ferroptosis-targeting strategies into real-world therapies faces practical development challenges
Current substitutes like agar or gelatin often fail to replicate creaminess, leaving the product rigid and unappealing